Capgemini, Fresenius & Salesforce Team Up for Next-Gen CRM Solution
Capgemini, in collaboration with Fresenius and Salesforce, is developing a next-generation CRM solution. This move comes as Fresenius transitions from Veeva to Salesforce, aiming to unify digital interactions and engagement across its Pharma, BioPharma, Nutrition & MedTech business units.
The new CRM solution will manage the entire commercial lifecycle, standardising processes worldwide and ensuring regulatory compliance. Capgemini, acting as the strategic partner, will define, develop, and implement this solution.
Life sciences companies are urged to reassess their CRM strategies due to the impending Veeva-Salesforce split. Fresenius' 'PULSE' transformation program exemplifies this, as it shifts to the Salesforce Life Sciences Cloud to streamline processes and gain advanced data insights. Modern CRM systems now expand beyond customer engagement to include patient-centric capabilities and global operation management.
By leveraging modern CRM technology and strategic partnerships, life sciences companies can strengthen customer engagement, drive growth, and enable precise decision-making. Fresenius' transition to Salesforce underscores the importance of staying competitive and avoiding disruptions in the face of changing market dynamics.
